Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

5
Number of overlapping holdings
16.7%
% of MEDX's 30 holdings also in THNR
21.7%
% of THNR's 23 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus THNR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in THNR |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 16.8% | 15.7% | 15.7% | |
ASTRAZENECA PLC-SPONS ADR | 5.6% | 4.7% | 4.7% | |
AMGEN INC | 6.3% | 4.6% | 4.6% | |
PFIZER INC | 4.0% | 4.6% | 4.0% | |
MERCK & CO. INC. | 3.6% | 4.7% | 3.6% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to THNR
ABBVIE INC | 9.6% | |
NOVARTIS AG-ADR | 6.6% | |
BRISTOL-MYERS SQUIBB CO | 6.5% | |
JOHNSON & JOHNSON | 5.1% | |
ALNYLAM PHARMACEUTICALS INC | 4.7% | |
ALKERMES PLC | 4.7% | |
REGENERON PHARMACEUTICALS | 2.8% | |
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% | |
BIOGEN IDEC INC | 2.6% | |
CRISPR THERAPEUTICS AG | 2.4% |
MEDX Underweight Relative to THNR
NOVO-NORDISK A/S-SPONS ADR | -13.9% | |
CHUGAI PHARMACEUTICAL CO LTD | -5.2% | |
WEST PHARMACEUTICAL SERVICES | -5.1% | |
THERMO FISHER SCIENTIFIC INC | -5.0% | |
ROCHE HOLDING LTD | -4.7% | |
INNOVENT BIOLOGICS, INC. | -4.7% | |
TEVA PHARMACEUTICAL-SP ADR | -4.5% | |
HIMS & HERS HEALTH, INC. CLASS A | -3.6% | |
MITSUBISHI CHEMICAL HOLDINGS | -3.5% | |
ZEALAND PHARMA A/S | -2.7% |